Two in three hesitant people shift to say 'yes' to vaccine

Embargoed until: Publicly released: 2021-09-25 01:00

International

Covid-19 vaccine hesitancy waned between late 2020 and early 2021, in a US study of more than 3,000 people. Nearly one in three who were first hesitant had been vaccinated, and more than one in three moved to being willing to be jabbed, when they were surveyed again in March-April 2021. The remainder said they were still unlikely to get the jab. The authors note that vaccines weren’t available to all who took part until after the follow-up survey, which is a limitation.

Media release

From: JAMA

Association of Initial COVID-19 Vaccine Hesitancy With Subsequent Vaccination

What The Study Did: This survey study found that COVID-19 vaccine hesitancy decreased between late 2020 and early 2021, with nearly one-third of survey participants who were initially hesitant being vaccinated at follow-up and more than one-third transitioning from vaccine hesitant into vaccine willing.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page Public link after embargo lifts

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: Emory University, US; Georgia State University, US

Funder: Conflict of Interest Disclosures: Dr Siegler reported receiving grants from the National Institutes of Health (NIH) and the Woodruff Foundation paid to his institution during the conduct of the study. Dr Sanchez reported receiving grants from the NIH during the conduct of the study. Dr Sullivan reported receiving grants and personal fees from the NIH during the conduct of the study, grants and personal fees from the Centers for Disease Control and Prevention, and grants from Gilead Sciences outside the submitted work. No other disclosures were reported. Funding/Support: Salesforce donated licenses and system development, and the Kaiser Family Foundation provided design contributions. This study was supported by the National Institute of Allergy and Infectious Diseases (grant 3R01AI143875-02S1 to Dr Siegler). Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Media Contact/s

Contact details are only visible to registered journalists.